<DOC>
	<DOCNO>NCT00002631</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . It know whether high-dose radiation therapy effective standard dose radiation therapy treat cancer esophagus . PURPOSE : Randomized phase III trial compare effectiveness combination chemotherapy plus high- standard-dose radiation therapy treat patient cancer esophagus .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Cancer Esophagus</brief_title>
	<detailed_description>OBJECTIVES : I . Compare , use prospective control randomize study design , survival failure pattern associate conventional-dose radiotherapy fluorouracil/cisplatin ( 5-FU/CDDP ) vs. high-dose radiotherapy 5-FU/CDDP patient esophageal cancer . II . Compare tolerance quality life patient receive therapy . OUTLINE : Randomized study . Arm I : Radiotherapy plus 2-Drug Combination Chemotherapy/Radiosensitization . Tumor irradiation use megavoltage photon least 6 MV ( electron may use require boost supraclavicular fossa dose ) ; plus Cisplatin , CDDP , NSC-119875 ; Fluorouracil , 5-FU , NSC-19893 . High-dose radiotherapy . Arm II : Radiotherapy plus 2-Drug Combination Chemotherapy/Radiosensitization . Tumor irradiation Arm I ; plus CDDP/5-FU . Conventional-dose radiotherapy . PROJECTED ACCRUAL : Up 298 patient enter 4 year .</detailed_description>
	<mesh_term>Esophageal Neoplasms</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Biopsyproven primary squamous cell adenocarcinoma esophagus Clinical Stage T14 , Nx , M0 disease require Disease entirely confine esophagus periesophageal soft tissue tumor extension within 2 cm proximal stomach No biopsyproven invasion trachealbronchial tree trachealesophageal ( TE ) fistula Bronchoscopy trachealbronchial tree require lesion less 30 cm incisor exclude TE fistula Negative liver biopsy require liver CT suggestive metastatic disease Negative biopsy require enlarge ( 1.5 cm great ) retroperitoneal celiac node see CT Negative biopsy clinically radiographically positive supraclavicular node require cervical primary No recurrent disease No multiple carcinoma esophagus PATIENT CHARACTERISTICS : Age : 18 Performance status : Karnofsky 60 % 100 % Hematopoietic : WBC least 4,000 Platelets least 150,000 Hb least 10 g/dL Hepatic : Not specify Renal : Creatinine normal OR Creatinine clearance least 65 mL/min Nutrition : Recommended oral intake requirement ( mouth tube feed ) : More 1.5 x Basal Energy Expenditure ( BEE ) measure Harris Benedict equation OR More 1,000 calories/sqm body surface area ( BSA ) Intravenous hyperalimentation ( recommended inadequate oral intake ) : 1.752.25 x BEE OR 1,2001,600 calories/sqm BSA Upper limit may waive hypermetabolic patient Other : No second malignancy within 5 year except : Curable nonmelanomatous skin cancer Cervical cancer situ No pregnant nursing woman PRIOR CONCURRENT THERAPY : Biologic therapy : No prior concurrent growth factor administration Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior chest irradiation Surgery : No prior resection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>stage I esophageal cancer</keyword>
	<keyword>stage II esophageal cancer</keyword>
	<keyword>stage III esophageal cancer</keyword>
	<keyword>squamous cell carcinoma esophagus</keyword>
	<keyword>adenocarcinoma esophagus</keyword>
</DOC>